Nexen Bio announced on the 12th that it has exercised the conversion rights of an 8.4 billion KRW anonymous, non-guaranteed, privately placed convertible bond with detachable warrants. The number of shares issued is 4,383,565.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing